Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

12.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mobilization of the ancient resistome from thawing permafrost.

Critical reviews in microbiology·2026
Same author

Domain knowledge embedded anti-disturbance autonomous navigation for marine vehicles.

Communications engineering·2026
Same author

Dynamics of suspended atmospheric microplastics and their wet deposition in the Qilian Mountains, Northeast Tibetan Plateau.

Journal of environmental sciences (China)·2026
Same author

A Fibrous-Porous Microsphere-Based Composite Filler for Synchronized Immediate and Long-Term Soft Tissue Restoration.

ACS applied materials & interfaces·2026
Same author

Unraveling the science of "sinking and dark-colored" superior agarwood through density, color, and metabolomics.

RSC advances·2026
Same author

Piezoelectric Materials in Bone Organoids.

Advanced healthcare materials·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.4K

Self-assembling RATEA16 peptide nanofiber designed for rapid hemostasis.

Shuda Wei1, Fangping Chen2, Zhen Geng1

  • 1Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, P. R. China. fpchen@ecust.edu.cn.

Journal of Materials Chemistry. B
|February 11, 2020
PubMed
Summary

A new polypeptide material, RATEA16, shows excellent biocompatibility and rapid hemostasis. This self-assembling peptide effectively stops bleeding in animal models, offering a promising solution for uncontrolled hemorrhage.

More Related Videos

Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility
05:24

Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility

Published on: September 6, 2024

1.6K
ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly
16:33

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly

Published on: April 17, 2014

12.9K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.4K
Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility
05:24

Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility

Published on: September 6, 2024

1.6K
ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly
16:33

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly

Published on: April 17, 2014

12.9K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Biochemistry

Background:

  • Uncontrolled bleeding is a major cause of mortality in trauma.
  • There is a critical need for advanced hemostatic agents with rapid action, biocompatibility, and ease of use.

Purpose of the Study:

  • To synthesize and characterize a novel polypeptide material, RATEA16.
  • To evaluate the self-assembly, gelation, biocompatibility, and hemostatic efficacy of RATEA16 in vitro and in vivo.

Main Methods:

  • Solid-phase synthesis of the polypeptide RATEA16.
  • Analysis of secondary structure and self-assembly into nanofibers.
  • In vitro and in vivo assessment of biocompatibility and hemostatic performance using an animal liver model.

Main Results:

  • RATEA16 exhibited appropriate pH and significant self-assembly into nanofibers.
  • The material demonstrated good biocompatibility and rapid gelation.
  • In vivo studies showed RATEA16 achieved complete hemostasis in approximately 40 seconds, outperforming commercial agents.

Conclusions:

  • The self-assembled polypeptide RATEA16 possesses excellent biocompatibility and efficient hemostatic properties.
  • RATEA16 is a promising candidate for a novel hemostatic agent for rapid bleeding control.